Coventry, United Kingdom

Victor Malcolm Clark

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Laboratories Limited. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victor Malcolm Clark. Retrieved from https://idiyas.com/inventor/victor-malcolm-clark

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Victor Malcolm Clark: Innovator in Pharmaceutical Chemistry

Introduction

Victor Malcolm Clark is a notable inventor based in Coventry, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of synthetic intermediates for antibiotics.

Latest Patents

Clark holds a patent for the "Preparation of 2-aryl-2-hydroxyiminoacetic acids (syn isomers)." This innovative process involves the reaction of an arylglyoxylic acid with hydroxylamine in an aqueous medium, such as water, in the presence of magnesium, calcium, or zinc ions. The resulting acids are valuable as synthetic intermediates in the preparation of penicillin and cephalosporin antibiotics that contain syn-2-aryl-2-hydroxyiminoacetamido side chains. He has 1 patent to his name.

Career Highlights

Victor Malcolm Clark has worked with Glaxo Laboratories Limited, a prominent company in the pharmaceutical industry. His work has contributed to advancements in antibiotic development, showcasing his expertise in the field.

Collaborations

Throughout his career, Clark has collaborated with notable colleagues, including Gordon Ian Gregory and Godfrey Basil Webb. These collaborations have further enhanced his contributions to pharmaceutical innovations.

Conclusion

Victor Malcolm Clark's work in the preparation of synthetic intermediates for antibiotics highlights his importance in the field of pharmaceutical chemistry. His innovative approaches continue to influence the development of essential medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…